pharma · Total Laryngectomy · Breast Cancer · ATOS
ATOSSA THERAPEUTICS
ATOSSA THERAPEUTICS, INC.
Athos Therapeutics is a pharma organization headquartered in Torrance, USA. It trades on NYSE under ticker ATOS. Primary therapeutic focus areas include Total Laryngectomy, Breast Cancer, Breast Cancer, Preneoplastic Con
Company details
- Status
- Public
- HQ
- Torrance, USA
- Founded
- 2019
- Employees
- 36
- Programs
- 10
- Drugs
- 5
- Patents
- 8
ForeCYTE Breast Aspirator
Phase 3 · other · Breast Cancer, Preneoplastic Conditions, BRCA
ForeCYTE Breast Aspirator for Breast Cancer, Preneoplastic Conditions, BRCA is a Phase 3 program (other) at ATOSSA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code GCP005
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ATOSSA THERAPEUTICS, INC.
- Phase
- Phase 3
- Modality
- other
- Indication
- Breast Cancer, Preneoplastic Conditions, BRCA
- Status
- terminated
- Trials
- 1